Concepedia

Hamim Zahir

HZ

29

Publications

1.5K

Citations

18

H-Index

2001

Active since

Affiliations

Daiichi Sankyo (United States)(Current)

Daiichi-Sankyo (Japan)

Daiichi Sankyo (Germany)

Dana-Farber Cancer Institute

The University of Sydney

Hamim Zahir is an author at Daiichi Sankyo (United States) specializing in medicine, pharmacology, and pharmacotherapy.

ORCID

Top concepts

Publications per year

2001–2022

29

Publications

29

Edoxaban Effects on Bleeding Following Punch Biopsy and Reversal by a 4-Factor Prothrombin Complex Concentrate

Hamim Zahir, Karen Brown, Alexander G. Vandell et al. · Circulation · 2014 · 250 citations

Drug-Drug Interaction Studies of Cardiovascular Drugs Involving P-Glycoprotein, an Efflux Transporter, on the Pharmacokinetics of Edoxaban, an Oral Factor Xa Inhibitor

Jeanne Mendell, Hamim Zahir, Nobuko Matsushima et al. · American Journal of Cardiovascular Drugs · 2013 · 221 citations · Full text

Factors affecting variability in distribution of tacrolimus in liver transplant recipients

Hamim Zahir, Geoffrey W. McCaughan, M. H. Gleeson et al. · British Journal of Clinical Pharmacology · 2004 · 112 citations · Full text

Validation of methods to study the distribution and protein binding of tacrolimus in human blood

Hamim Zahir, Romina A. Nand, Kenneth Brown et al. · Journal of Pharmacological and Toxicological Methods · 2001 · 98 citations

, , +4

Edoxaban drug–drug interactions with ketoconazole, erythromycin, and cyclosporine

Dolly A. Parasrampuria, Jeanne Mendell, Minggao Shi et al. · British Journal of Clinical Pharmacology · 2016 · 94 citations · Full text

Rows per page

1–5 of 29